AKTX vs STZ · $17.2M cap vs P/E 14, rev $9.14B
Akari Therapeutics PLC (AKTX) versus Constellation Brands Inc Class A (STZ) — a side-by-side from cached financials, not a winner call.
Akari Therapeutics PLC (AKTX) is a biotechnology company listed on US.
Constellation Brands Inc Class A (STZ) is a beverages - brewers company listed on US.
AKTX does not have a complete income-statement cache yet.
Latest reported STZ revenue for 2026-02-28 was $9.14B. Net income was $1.69B. Revenue was up 322.3% from 2025-02-28 to 2026-02-28. STZ currently screens at market cap $23.73B and trailing P/E 14.4.
AKTX currently screens at market cap $17.2M. STZ currently screens at market cap $23.73B and trailing P/E 14.4.
Not investment advice. Open the AKTX and STZ stock pages for the full models.
Not investment advice.